Jiangsu Hengrui Medicine Co., Ltd. announced earnings results for the nine months ended September 30, 2019. For the nine months, the company announced sales was CNY 16,945.046 million compared to CNY 12,458.768 million a year ago. Operating income was CNY 4,457.604 million compared to CNY 3,512.968 million a year ago. Net income was CNY 3,734.893 million compared to CNY 2,911.920 million a year ago. Basic earnings per share from continuing operations was CNY 0.84 compared to CNY 0.66 a year ago. Diluted earnings per share from continuing operations was CNY 0.84 compared to CNY 0.65 a year ago.